Physician profile
Owais Malick
NPI 1326337130
$77,776.55
in general payments reported to CMS, 2019-2025
19 companies · $17K in 2025
The $17K reported for 2025 was more than what 82% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $192 · 2021: $588 · 2022: $8,575 · 2023: $23K · 2024: $28K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Travel and Lodging: $6,445 · Food and Beverage: $4,728 · Consulting Fee: $3,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53,920.00 |
| Travel and Lodging | $6,444.72 |
| Food and Beverage | $4,727.68 |
| Consulting Fee | $3,024.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $63,747.82 | 2021-2025 | Uptravi, Opsumit |
| Pfizer INC. | $7,466.82 | 2019-2024 | |
| Abiomed | $2,564.61 | 2021-2025 | Impella |
| Abbott Laboratories | $2,396.38 | 2019-2025 | Cardiomems, Thoratec Heartmate II, Lvas Implant Kit, Thoratec Heartmate 3 Lvas Implant Kit |
| Cvrx, INC. | $306.54 | 2021-2025 | Barostim Neo System |
| Ancora Heart, INC. | $298.59 | 2024-2025 | Accucinch |
| United Therapeutics Corporation | $204.55 | 2019-2020 | |
| Novo Nordisk INC | $175.39 | 2023-2024 | Wegovy |
| Edwards Lifesciences Corporation | $152.05 | 2025 | Pascal |
| Cardiva Medical, INC. | $96.32 | 2022 | |
| Novartis Pharmaceuticals Corporation | $61.42 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.83 | 2019-2025 | Jardiance |
| Scpharmaceuticals INC. | $55.50 | 2025 | |
| Heartflow, INC. | $50.77 | 2025 | |
| Philips North America LLC | $47.93 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $31.48 | 2025 | Uptravi |
| Amgen INC. | $24.76 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $20.67 | 2020 | |
| Endotronix, INC. | $16.12 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Owais Malick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.